FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

710287009: Obinutuzumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3044264018 Obinutuzumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3044436014 Obinutuzumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
51291000195116 obinutuzumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
828971000172113 obinutuzumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65511000195116 Obinutuzumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Obinutuzumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Obinutuzumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Obinutuzumab (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing obinutuzumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Obinutuzumab (substance) Inferred relationship Some 1
Obinutuzumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Obinutuzumab (substance) Inferred relationship Some 1
Obinutuzumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Obinutuzumab (substance) Inferred relationship Some 1
Product containing only obinutuzumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Obinutuzumab (substance) Inferred relationship Some 1
Product containing precisely obinutuzumab 25 milligram/1 milliliter conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Obinutuzumab (substance) Inferred relationship Some 1
Product containing precisely obinutuzumab 25 milligram/1 milliliter conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Obinutuzumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start